Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

Rheumatology (Oxford). 2008 Apr;47(4):552-3. doi: 10.1093/rheumatology/kem357. Epub 2008 Feb 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Pulmonary Fibrosis / drug therapy*
  • Rituximab
  • Scleroderma, Systemic / complications*
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab